Streetbeat News

Stock Prices

BWXT

BWX Technologies (NYSE:BWXT) reported Q1 2024 earnings of $0.76 per share, surpassing the $0.69 estimate, marking a 10.14% beat and an 8.57% increase from the previous year. Sales reached $603.933M, exceeding estimates by 0.67% and showing a 6.26% year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 8:07 pm

SYM

Symbotic's stock price increased following the announcement of mixed financial results for the second quarter. The company, trading under the symbol SYM, experienced a positive market reaction despite the mixed outcomes in its quarterly financial performance.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 8:07 pm

AORT

Artivion reported Q1 2024 adjusted EPS of $0.06, surpassing the $(0.11) estimate, and sales of $97.431M, exceeding the $91.978M forecast. This represents a 200% increase in EPS and a 17.06% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 8:07 pm

HIMS

Hims & Hers Health (HIMS) reported Q1 2024 earnings of $0.05 per share, surpassing the $0.02 estimate, with sales of $278.171M beating the $270.382M estimate, marking a 45.81% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 8:06 pm

SWAV

ShockWave Medical (NASDAQ:SWAV) exceeded Q1 earnings and sales estimates with EPS of $1.44 against a $0.98 forecast and sales of $218.81M versus an expected $207.69M. This represents a 39.81% and 35.85% increase in earnings and sales, respectively, compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 8:05 pm

VRTX

Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q1 2024 earnings of $4.76 per share, surpassing the $4.06 estimate, a 56.07% increase from last year. Sales reached $2.690B, beating the $2.579B estimate, marking a 13.26% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 8:05 pm

ENTA

Enanta Pharma (NASDAQ:ENTA) reported Q2 2024 earnings with a GAAP EPS of $(1.47), missing the $(1.33) estimate by 10.53%, and sales of $17.054M, beating the $16.522M estimate by 3.22%. This represents a 17.88% improvement in EPS and a 4.16% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 8:05 pm

KVHI

KVH Industries (NASDAQ:KVHI) reported Q1 2024 GAAP EPS of $(0.16), beating the $(0.19) estimate but saw a 900% decrease in earnings compared to last year. Sales were $29.267M, missing the $31.880M estimate, marking a 14.28% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 8:05 pm

ASRT

Assertio Holdings (NASDAQ:ASRT) reported Q1 2024 adjusted EPS of $0.04, surpassing the $(0.03) estimate, with sales of $32.448M beating the $29.512M forecast. This represents a significant decrease in earnings and sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 8:05 pm

CLDX

Celldex Therapeutics (NASDAQ:CLDX) reported Q1 earnings with a loss of $(0.56) per share, surpassing the expected $(0.69) loss, marking an 18.84% beat. However, their sales of $156.00K fell short of the $920.00K estimate, an 83.04% miss, and represented an 83.87% decrease from the previous year's $967.00K.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 8:04 pm